Alra Skincare was born out of a personal mission to heal, and today we’re proud to serve more than 200 cancer centers across the United States. Our products are used and recommended by oncologists, nurses, and wellness coordinators to help patients care for their skin during and after treatment.
As we continue this mission, our approach has evolved — from simply soothing the skin to helping it function and renew itself. This evolution led us to develop a new category: Acid-Based Skincare.
Instead of harsh exfoliation, our gentle molecular acids (AHA, BHA, PHA) work in harmony with the skin, supporting the barrier while restoring permeability — the skin’s natural ability to absorb, breathe, and respond. When the skin is receptive, actives like Vitamin C, ceramides, and botanical antioxidants can finally reach where they are needed most.
Today, Alra remains rooted in compassion and guided by science — creating formulas that are safe for medically sensitive skin yet effective enough to transform texture, radiance, and resilience.
From healing skin to awakening its potential — this is Alra’s new generation of care.
40 Years of Sensitive Skincare Innovation
From a cancer patient’s need to nationwide hospital trust—discover the Alra story.
Neue Cosmetic founded; formulated lotion for cancer care
In 1982, the founder established Neue Cosmetic and developed an innovative lotion specifically designed to help cancer patients. This groundbreaking formulation aimed to restore and protect sensitive, damaged skin during rigorous cancer treatments.
Alra brand launched in Los Angeles, USA
In 1987, the Alra brand was officially launched in Los Angeles, marking the beginning of its commitment to delivering effective, safe skincare products. With roots in medical care, Alra set out to provide solutions for patients with unique skin needs.
Entered 200+ U.S. Oncology Treatment Hospitals
By the year 2000, Alra’s trusted formulations were adopted by over 200 leading oncology treatment hospitals in the United States, including renowned institutions like the Mayo Clinic and Cleveland Clinic, proving its clinical reliability and efficacy.
Featured by The New York Times for impact
In 2008, The New York Times highlighted Alra’s significant contributions to cancer skin care, acknowledging its pioneering role and the positive impact it had on enhancing patient recovery through innovative skincare solutions.
Included in top hospital clinical care handbooks
In 2016, Alra’s products were incorporated into clinical care handbooks at top U.S. hospitals, such as Northwestern Memorial Hospital and the University of Michigan, solidifying its reputation as a hospital-endorsed, medically trusted skincare solution.
Began online sales through e-commerce platforms worldwild
In 2018, Alra transitioned into the digital marketplace by launching online sales channels. This move made its trusted skincare formulations accessible to a global audience, paving the way for broader consumer engagement.
Rebranded; launched serums for sensitive skin concerns
In 2023, Alra underwent a comprehensive rebranding to better serve the growing demand for sensitive skincare. Along with the brand refresh, innovative serums specifically targeting irritation and barrier repair for sensitive skin were launched, expanding the product line beyond its original focus.
Partnered with NBCF for breast cancer support
In 2024, Alra entered a strategic partnership with the National Breast Cancer Foundation (NBCF). This collaboration not only reinforces the brand’s commitment to cancer care but also expands its mission to support broader healthcare initiatives and patient well-being.
What We Stand For
